X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
7-36 amide (412) 412
humans (374) 374
endocrinology & metabolism (365) 365
glucagon-like peptide-1 (338) 338
animals (323) 323
male (312) 312
glucagon-like peptide 1 (301) 301
gastric-inhibitory polypeptide (210) 210
female (189) 189
glp-1 (183) 183
rats (182) 182
glucagon (171) 171
index medicus (169) 169
glucose (158) 158
insulin (158) 158
insulin - blood (142) 142
diabetes mellitus, type 2 - drug therapy (139) 139
peptide fragments - pharmacology (136) 136
blood glucose - metabolism (134) 134
incretin (131) 131
type 2 diabetes (131) 131
secretion (125) 125
adult (122) 122
insulin - metabolism (122) 122
insulin secretion (122) 122
middle aged (113) 113
glucagon-like peptides (112) 112
physiology (99) 99
glucagon-like peptide-1 receptor (98) 98
pharmacology & pharmacy (97) 97
diabetes (94) 94
glucagon - blood (91) 91
glucagon - metabolism (91) 91
healthy-subjects (86) 86
glucagon - pharmacology (85) 85
insulin-secretion (84) 84
mice (82) 82
peptide fragments - metabolism (81) 81
dependent insulinotropic polypeptide (79) 79
biochemistry & molecular biology (78) 78
diabetes mellitus, type 2 - blood (78) 78
peptides (76) 76
diabetes-mellitus (74) 74
hypoglycemic agents - therapeutic use (70) 70
physiological aspects (68) 68
protein precursors - pharmacology (68) 68
receptor (67) 67
hormone (66) 66
peptides - pharmacology (65) 65
expression (64) 64
pancreas (64) 64
dose-response relationship, drug (63) 63
peptide fragments - blood (63) 63
peptide-1amide (61) 61
aged (60) 60
gip (60) 60
glucose tolerance test (60) 60
rats, wistar (60) 60
blood glucose - drug effects (56) 56
incretin hormones (56) 56
diabetes mellitus, type 2 - metabolism (55) 55
amide (54) 54
glucagon-like peptide 1 - metabolism (54) 54
research (53) 53
degradation (52) 52
blood glucose - analysis (51) 51
polypeptide (51) 51
dextrose (50) 50
food-intake (50) 50
glucose - metabolism (50) 50
obesity (50) 50
time factors (50) 50
in-vivo (49) 49
peptide fragments - physiology (49) 49
protein precursors - metabolism (49) 49
release (49) 49
mellitus (48) 48
peptide fragments - administration & dosage (48) 48
proglucagon (48) 48
hyperglycemia (47) 47
protein precursors - blood (47) 47
glucagon-like peptide 1 - pharmacology (46) 46
c-peptide - blood (45) 45
diabetes mellitus, type 2 - physiopathology (45) 45
gene-expression (45) 45
glucagon - physiology (45) 45
glucagon-like peptide 1 - analogs & derivatives (45) 45
glucose metabolism (44) 44
glycemic control (44) 44
in-vitro (44) 44
liraglutide (43) 43
peptide fragments - therapeutic use (43) 43
double-blind method (42) 42
medicine, research & experimental (42) 42
kinetics (41) 41
exendin-4 (40) 40
glucagon - therapeutic use (40) 40
glucose-tolerance (40) 40
rats, sprague-dawley (40) 40
type-2 diabetes-mellitus (40) 40
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 12/2017, Volume 146, pp. 165 - 173
Journal Article
Chemico-Biological Interactions, ISSN 0009-2797, 04/2013, Volume 203, Issue 2, pp. 530 - 541
► We find out -glutamine increased glucagon like peptide-1. ► It increased mRNA expression for GLP-1. ► It improved glycemia, insulin release and active GLP-1... 
Docking | Antioxidant parameters | GLP-1 (7-36) amide | l-glutamine | Proglucagon gene expression | Insulin secretion | OXIDATIVE STRESS | L-glutamine | RECEPTOR AGONISTS | BIOCHEMISTRY & MOLECULAR BIOLOGY | GLIDE | CELL-PROLIFERATION | GLUCAGON-LIKE PEPTIDE-1 | ACCURATE DOCKING | GLUTATHIONE | PHARMACOLOGY & PHARMACY | TOXICOLOGY | STREPTOZOTOCIN | Triazoles - administration & dosage | Glycated Hemoglobin A - metabolism | Pyrazines - administration & dosage | Colon - drug effects | Body Weight - drug effects | Glutamine - metabolism | Glucagon-Like Peptide 1 - blood | Male | Pyrazines - metabolism | Insulin - blood | Glucagon-Like Peptide 1 - genetics | Glucagon-Like Peptide 1 - secretion | Diabetes Mellitus, Experimental - blood | Peptide Fragments - blood | Glutamine - pharmacology | Sitagliptin Phosphate | Diabetes Mellitus, Experimental - metabolism | Peptide Fragments - genetics | Diabetes Mellitus, Experimental - physiopathology | Glucose Tolerance Test | Peptide Fragments - metabolism | Glucagon-Like Peptide 1 - metabolism | Administration, Oral | Niacinamide - adverse effects | Peptide Fragments - secretion | Pancreas - drug effects | Pancreas - pathology | Rats | Receptors, Glucagon - metabolism | Pancreas - metabolism | Rats, Sprague-Dawley | Colon - metabolism | Gene Expression Regulation - drug effects | Triazoles - pharmacology | Triazoles - metabolism | Insulin - metabolism | Animals | Glucagon-Like Peptide-1 Receptor | Glutamine - administration & dosage | Lipid Metabolism - drug effects | Receptors, Glucagon - chemistry | Protein Conformation | Drinking - drug effects | Molecular Docking Simulation | Oxidative Stress - drug effects | Blood Glucose - metabolism | Pyrazines - pharmacology | Antioxidants | Niacinamide | Drugstores | Diabetes | Gene expression | Diabetes therapy | Glutamine
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 01/2013, Volume 698, Issue 1-3, pp. 470 - 479
In previous study, we have reported cycloart-23-ene-3β, 25-diol is an active antidiabetic constituent isolated from stem bark of (Linn.) Pierre. The objective... 
GLP-1 (7–36) amide | Oral glucose tolerance test | Antioxidant markers | Plasma glucose | Pancreatic β cells | mRNA proglucagon gene expression | Cycloart-23-ene-3β | 25-diol | Insulin | GLP-1 (7-36) amide | SYSTEM | Pancreatic beta cells | OXIDATIVE STRESS | PHYSIOLOGY | CELL-PROLIFERATION | PEPTIDE-1 RECEPTOR AGONISTS | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | Cycloart-23-ene-3 beta | ACCURATE DOCKING | GLUTATHIONE | GLUCAGON-LIKE PEPTIDES | PHARMACOLOGY & PHARMACY | MICE | Triazoles - administration & dosage | Diabetes Mellitus, Experimental - drug therapy | Triterpenes - pharmacology | Pyrazines - administration & dosage | Triterpenes - therapeutic use | Body Weight - drug effects | Male | Pyrazines - metabolism | Pyrazines - therapeutic use | Insulin - blood | Glucagon-Like Peptide 1 - secretion | Diabetes Mellitus, Experimental - blood | Time Factors | Glucagon-Like Peptide 1 - agonists | Sitagliptin Phosphate | Diabetes Mellitus, Experimental - metabolism | Triterpenes - metabolism | Diabetes Mellitus, Experimental - physiopathology | Triazoles - therapeutic use | Biomarkers - metabolism | Glucose Tolerance Test | Peptide Fragments - metabolism | Glucagon-Like Peptide 1 - metabolism | Niacinamide - adverse effects | Peptide Fragments - secretion | Pancreas - drug effects | Rats | Glucagon-Like Peptide 1 - chemistry | Pancreas - metabolism | Rats, Sprague-Dawley | Gene Expression Regulation - drug effects | Triazoles - pharmacology | Triazoles - metabolism | Insulin - metabolism | Peptide Fragments - chemistry | Animals | Peptide Fragments - agonists | Protein Conformation | Drinking - drug effects | Molecular Docking Simulation | Oxidative Stress - drug effects | Blood Glucose - metabolism | Pyrazines - pharmacology | Triterpenes - administration & dosage
Journal Article
by Wu, WD and Sheng, K and Xu, XL and Zhang, HB and Zhou, GH
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, ISSN 0147-6513, 05/2018, Volume 153, pp. 181 - 187
Anorexia is a hallmark of animal and human exposed to T-2 toxin, a most poisonous trichothecene mycotoxins contaminating various cereal grains including wheat,... 
Anorexia | DEOXYNIVALENOL VOMITOXIN | GASTRIN RECEPTORS | FOOD-INTAKE | Mycotoxin | MOUSE | RATS | T-2 toxin | BRAIN CHOLECYSTOKININ | ENVIRONMENTAL SCIENCES | Gut satiety hormone | ORAL-EXPOSURE | CCK2 RECEPTORS | CENTRAL-NERVOUS-SYSTEM | GASTROINTESTINAL HORMONES | TOXICOLOGY | Cholecystokinin | Glucagon-like peptide-1(7-36) amide
Journal Article
Journal Article
JOURNAL OF CLINICAL INVESTIGATION, ISSN 0021-9738, 04/1998, Volume 101, Issue 7, pp. 1421 - 1430
The gastrointestinal hormone, glucagon-like peptide-1(7-36)amide (GLP-1) is released after a meal, The potency of synthetic GLP-1 in stimulating insulin... 
MEDICINE, RESEARCH & EXPERIMENTAL | GLP-1 | insulin | RAT PANCREAS | INHIBITORY POLYPEPTIDE | entero-insulinar axis | PEPTIDE-1 7-36 AMIDE | PHYSIOLOGICAL INCRETIN | DIABETES-MELLITUS | FUNCTIONAL EXPRESSION | GENE-EXPRESSION | glucagon | GASTRIC-ACID SECRETION | INSULINOTROPIC POLYPEPTIDE RECEPTOR | CELL-LINE | exendin(9-39)amide
Journal Article
Diabetologia, ISSN 0012-186X, 11/1996, Volume 39, Issue 12, pp. 1546 - 1553
Intravenous glucagon-like peptide (GLP)-1 [7–36 amide] can normalize plasma glucose in non-insulin-dependent diabetic (NIDDM) patients. Since this is no form... 
36 amide | GLP-1 | Medicine & Public Health | Human Physiology | insulin | incretin | Metabolic Diseases | pharmacokinetics | Internal Medicine | glucagon | GLP-1 [7-36 amide] | HEALTHY-SUBJECTS | PANCREAS | DIABETES-MELLITUS | HORMONE | INJECTION | IN-VIVO | 7-36-AMIDE | ENDOCRINOLOGY & METABOLISM | DEGRADATION | GASTRIC-INHIBITORY POLYPEPTIDE | Gastrointestinal Hormones - pharmacokinetics | Glucagon-Like Peptide 1 | C-Peptide - blood | Humans | Middle Aged | Peptides - pharmacokinetics | Gastrointestinal Hormones - pharmacology | Male | Peptide Fragments - pharmacology | Insulin - blood | Glucagon - blood | Peptides - administration & dosage | Gastrointestinal Hormones - adverse effects | Glucagon-Like Peptides | Fasting - blood | C-Peptide - drug effects | Injections, Subcutaneous | Adult | Female | Fasting - metabolism | C-Peptide - metabolism | Peptide Fragments - administration & dosage | Peptide Fragments - pharmacokinetics | Glucagon - drug effects | Peptides - pharmacology | Gastrointestinal Hormones - administration & dosage | Diabetes Mellitus, Type 2 - blood | Insulin - metabolism | Diabetes Mellitus, Type 2 - physiopathology | Gastric Emptying - drug effects | Gastric Emptying - physiology | Glucagon - metabolism | Aged | Peptide Fragments - adverse effects | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Peptides - adverse effects | Cohort Studies
Journal Article